Delivery Order SPE2DB20D7061-SPE2DB25FSLG0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,678.60 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract, executed on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,342.88 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract was awarded on July 28, 2025, with completion targeted for July 29, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $15,047.43 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the...
- The Defense Logistics Agency awarded a $2,014.32 delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is due for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order, this delivery is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,007.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials each). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded procurement. This...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. This firm fixed price, non-set-aside contract is scheduled for completion by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,014.32 to AmerisourceBergen Drug Corp for the provision of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform delivery at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,090.46 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kit (2 vials). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $3,357.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials), with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a pediatric meningococcal vaccine delivery under the company's existing pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSLG0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,326.80 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. The contract, executed on November 19, 2024, with an ultimate completion date of November 20, 2024, represents a firm fixed-price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with extensive experience fulfilling competitive federal medical procurement requirements across diverse therapeutic domains. The company's primary role under the SPE2DX IDC encompasses the supply of specialty medications, brand-name and generic pharmaceuticals, vaccines, medical devices, and related healthcare commodities to support military healthcare programs globally, including services to the Defense Health Agency and U.S. Coast Guard. This particular vaccine delivery order exemplifies the routine pharmaceutical supply fulfillment conducted through the established prime vendor contract structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 11/19/24 |